References
- Aller-Moran L.M., Martinez-Lobo F.J., Rubio P., Carvajal A.: Evaluation of the in vitro activity of flumequine against field isolates of Brachyspira hyodysenteriae. Res Vet Sci 2015, 103, 51–53.
- Angela L.: Thyroid and Cholesterol: Does thyroid stimulating hormone (TSH) affect cholesterol levels? Clin Thyroidol 2012, 5, 3. https://www.thyroid.org/wp-content/uploads/publications/ctfp/volume5/issue12/ct_patients_v512_3.pdf.
- Cheng L., Ming-liang H., Lars B.: Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial. Acta Pharm Sin 2005, 26, 926–933.
- Cho J.H., Jeong S.H., Ku H.O., Kang H.G., Park J.M., Yun H.I., Lee Y.S.: Improved novel method of blood sample collection via jugular vein in unanaesthetized rats. Korean J Lab Anim Sci 1997, 13, 117–120.
- Cruz R., Quintana-Hau J.D., Gonzalez J.R., Tornero-Montano R., Baiza-Duran L.M., Vega L.: Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation. Br J Ophthalmol 2008, 92, 120–125.
- Fazili I.S., Jiang W., Wang L., Felix E.A., Khatlani T., Coumoul X., Barouki R., Moorthy B.: Persistent induction of cytochrome P4501A1 in human hepatoma cells by 3-methylcholanthrene: evidence for sustained transcriptional activation of the CYP1A1 promoter. J Pharmacol Exp Ther 2010, 333, 99–109.
- Geffner J.R., Minnucci F., Isturiz M.A.: Interferon-gamma is unable to increase monocyte and neutrophil-mediated nonspecific cytotoxicity induced by immune complexes. Immunol Lett 1992, 33, 21–25.
- Groelz D., Sobin L., Branton P., Compton C., Wyrich R., Rainen L.: Non-formalin fixative versus formalin-fixed tissue: A comparison of histology and RNA quality. Exp Mol Pathol 2013, 94, 188–194.
- Jensen H.S., Mogensen H.H., Kjaersgaard E.: Blood monocyte elastolytic activity enhanced by immune complex stimulation in patients with rheumatoid arthritis and normal controls. Effect of aurothiomalate or D-penicillamine. Scand J Rheumatol 1989, 18, 297–305.
- Jeong S.H., Kim B.Y., Kang H.G., Ku H.O., Cho J.H.: Effects of butylated hydroxyanisole on the development and functions of reproductive system in rats. Toxicology 2005, 208, 49–62.
- Joint FAO/WHO Expert Committee on Food Additives (JECFA): Toxicological evaluation of certain veterinary drug residues in food. World Health Organization, Geneva, Switzerland, 2004 WHO Food Additives Series: 51.
- Kang H.G., Jeong S.H., Cho J.H., Kim D.G., Park J.M., Cho M.H.: Chlropyrifos-methyl shows anti-androgenic activity without estrogenic activity in rats. Toxicology 2004, 199, 219–230.
- Kuroda K., Kijima A., Ishii Y., Takasu S., Jin M., Matsushita K., Kodama Y., Umemura T.: Flumequine enhances the in vivo mutagenicity of MeIQx in the mouse liver. Arch Toxicol 2013, 87, 1609–1619.
- Lopez-Giacoman S., Madero M.: Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol 2015, 4, 57–73.
- OECD/OCDE. OECD guideline for the testing of chemicals. Repeated dose 90-days oral toxicity study in rodents, 1998, p. 408.
- Rizos C.V., Elisaf M.S., Liberopoulos E.N.: Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J 2011, 5, 76–84.
- Sanderson J.T.: The Steroid Hormone Biosynthesis Pathway as a Target for Endocrine-Disrupting Chemicals. Toxicol Sci 2006, 94, 3–21.
- Scharer K.: The effect of chronic underfeeding on organ weights of rats. How to interpret organ weight changes in cases of marked growth retardation in toxicity tests? Toxicology 1977, 7, 45–56.
- Summary report (2) flumequine (EMEA/MRL/624/99-FINAL), Committee for veterinary medicinal products, the European Agency for the Evaluation of Medicinal Products. 1999.
- Van der Heijden M.H., Booms G.H., Tanck M.W., Rombout J.H., Boon J.H.: Influence of flumequine on in vivo mitogen responses of European eel (Anguilla anguilla L., 1758) lymphoid cells. Vet Immunol Immunopathol 1995, 47, 143–152.
- Yoshida M., Miyajima K., Shiraki K., AndoK K.J., Nakae D., Takahashi M., Maekawa A.: Hepatotoxicity and consequently increased cell proliferation are associated with flumequine hepatocarcinogenesis in mice. Cancer Lett 1999, 141, 99–107.